Table 3.
The correlation analysis between SCMs and IgG M protein in MM patients in Cohort 2.
| No. | SCM | r | P-value |
|---|---|---|---|
| 1 | Butyrylcarnitine | 0.705 | 0.000 |
| 2 | Valerylcarnitine | 0.439 | 0.036 |
| 3 | 2-Hexenoylcarnitine | 0.518 | 0.000 |
| 4 | N-Acetylornithine | 0.608 | 0.002 |
| 5 | Asymmetric dimethylarginine | 0.513 | 0.009 |
| 6 | 3-Dehydroxycarnitine | 0.548 | 0.007 |
| 7 | 5'-Methylthioadenosine | 0.568 | 0.005 |
| 8 | Creatinine | 0.445 | 0.033 |
| 9 | PC(16:0/16:0) | 0.417 | 0.048 |
| 10 | DL-Glutamate | 0.431 | 0.040 |
| 11 | 1-Methyladenosine | 0.053 | 0.811 |
| 12 | PC(18:3(6Z,9Z,12Z)/16:0) | 0.355 | 0.118 |
No., number; SCM, significantly changed metabolite.